Company intelligence / Profile preview
Wörwag Pharma
- Ownership
- Private
- Employees
- ~1450
- Development stage
- Other
Overview
Wörwag Pharma develops and markets prescription and over-the-counter medicines as well as food supplements focused on biofactors for diabetic comorbidities, nervous system, immune health, and musculoskeletal conditions. The company operates in over thirty-five countries with a broad commercial portfolio.[2][4]
- Therapeutic areas
- EndocrinologyRheumatologyImmunologyNeurology
- Modalities
- Small molecules (biofactors such as vitamins, minerals, trace elements)[3]
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Wörwag Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wörwag Pharma.